Lv1
20 积分 2023-02-15 加入
Appetite-suppressing effects of GIPR agonism and antagonism work through different brain regions
2天前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
10天前
已完结
The weight-loss-independent hepatoprotective benefits of semaglutide are orchestrated by intrahepatic sinusoidal endothelial GLP-1 receptors
10天前
已完结
The expanding landscape of GLP-1 medicines
10天前
已完结
Tirzepatide suppresses palatable food intake by selectively reducing preference for fat in rodents
10天前
已完结
The Paradox and Future of GLP-1/GIP Combination Therapies: Efficacy and Mechanisms
11天前
已完结
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
11天前
已完结
The evolving landscape of obesity pharmacotherapy
17天前
已完结
A High-Potency Protein That Normalizes Body Weight in DIO Mice through Triple Agonism at FGF21, GLP1, and GIP Receptors
20天前
已完结
The evolving landscape of obesity pharmacotherapy
20天前
已完结
皖公网安备34019202002308
